Anzeige
Mehr »
Dienstag, 23.06.2026 - Börsentäglich über 12.000 News
Schuldenfrei, 1,5 Mio. Unzen Gold und Produktion ab 2027: Vor dem Ausbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
124 Leser
Artikel bewerten:
(0)

AGS Health Expands Leadership Team, Deepening Its Commitment to RCM AI Innovation and Strategic Growth

WASHINGTON, D.C. / ACCESS Newswire / June 23, 2026 / In a reflection of its accelerating investment in AI, automation, data management, and company growth, AGS Health today announced the expansion of its executive leadership team. These appointments underscore the company's commitment to delivering on the promise of revenue cycle AI through practical innovation, clinical expertise, and ROI-driven solutions. As a provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers nationwide, AGS Health is focused on delivering measurable improvements in financial performance while enhancing the patient experience.

"Healthcare providers are navigating a highly complex and rapidly shifting industry landscape, one where reimbursement pressures, rising costs, workforce challenges, regulatory change, and the evolution of AI are converging in ways that demand more from their RCM partner than ever before. Providers don't just need a partner that keeps pace with change. They need one that anticipates it and turns it into a strategic advantage," said AGS Health Managing Director and CEO Patrice Wolfe. "The leaders we're announcing today aim to bring exactly the visionary thinking, customer-first mindset, and creative problem-solving it takes to do that. Together with our broader executive team, they will help AGS Health continue innovating on behalf of our clients and try to ensure every provider we serve has the footing to not just navigate this moment, but to thrive in it."

The appointments span four critical domains: commercial growth, AI and data, marketing, and customer success.

Cheryl Cruver was named President, US Markets & Chief Commercial Officer. Cruver, who was previously AGS Health's Chief Revenue Officer, has unified oversight of all revenue-generating functions, including sales, marketing, customer success, and transition functions. She will also play a key role in advancing AGS Health's AI-enabled transformation. Throughout her career, spanning more than three decades, Cruver has helped healthcare providers leverage data, technology, and innovation to strengthen financial performance, improve operational efficiency, and enhance patient outcomes.

Balaji Sundararajan was appointed to the newly created role of Chief Data and AI Officer (CDAIO), reflecting the central role of data and AI in AGS Health's strategy. In this role, Sundararajan will accelerate the development of the company's AI capabilities across its product portfolio and operations, oversee data governance and analytics, and promote data literacy and responsible AI use across the company. He previously served as AGS Health's Senior Vice President and Global Head of Engineering and brings more than 30 years of technology leadership experience, including two decades driving AI and automation innovation.

Susan Worthy joins AGS Health as Chief Marketing Officer, leading the company's global marketing strategy to drive growth and showcase innovation. Worthy brings to AGS Health a reputation for translating complex solutions into clear and compelling market narratives, aligning marketing with business priorities for health IT and tech-enabled services organizations, and building high-performing teams. Previously, she was CMO at Gainwell Technologies and has held marketing leadership roles at Amwell, Optum, and Aetna.

Joel Gleason was named Chief Customer Officer in addition to his existing role as Senior Vice President of Customer Success. He leads the company's customer success organization, working to deepen client relationships, expand its footprint, and help customers achieve their business objectives through AI-driven technology and embedded global services. With more than 30 years of health IT and services experience, Gleason brings a strong customer-first approach to his role, along with a reputation for building scalable teams, driving repeatable processes, and delivering measurable value and outcomes.

"Cheryl, Balaji, Susan, and Joel each bring exceptional depth in their disciplines, and together they strengthen our ability to deliver the AI-driven, outcomes-focused solutions our clients need to compete in today's healthcare environment," said Wolfe. "I'm proud to welcome our new executive team members and am confident this team will define what's possible for AI-driven revenue cycle management."

About AGS Health

AGS Health is a strategic growth partner to healthcare providers across the U.S. The company's approach combines award-winning services with intelligent automation and customer support to deliver end-to-end revenue cycle performance and an empowering patient financial experience. AGS Health employs a team of approximately 16,000 domain experts supporting customers across diverse care settings and specialties. For more information, visit www.agshealth.com

# # #

Media Contact:
Liz Goar, NPC Creative Services
liz@npccs.com

SOURCE: AGS Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ags-health-expands-leadership-team-deepening-its-commitment-to-rcm-ai-1179685

© 2026 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.